0.5%甲硝唑溶液在口内手术病人口腔护理的使用

目的分析和研究0.5%甲硝唑溶液作为口腔护理液对口内手术病人口腔并发症的预防及影响。方法选取2014年6月至2015年11月口腔科住院行口内手术的患者146例,随机分为观察组与对照组,每组各有患者73例,对照组患者给予常规口腔护理干预,观察组患者在常规口腔护理基础上加用0.5%甲硝唑溶液,将两组患者进行护理干预1周后发生口腔并发症的情况进行对比。结果观察组明显低于对照组(P﹤0.05)。结论在常规口腔护理基础上加入0.5%甲硝唑溶液对预防口腔并发症发生及减轻患者痛苦均具有重要作用。     

吡拉西坦氯化钠注射液治疗脑出血的临床疗效分析

目的 研究分析对脑出血患者使用吡拉西坦氯化钠注射液进行治疗的效果.方法 在本院治疗的脑出血患者中选取70例作为研究对象,将其中35例分为对照组,另外35例分为观察组.对照组患者使用甘露醇治疗,观察组患者使用吡拉西坦氯化钠治疗,对比两组患者治疗后的效果、不良反应发生率,以及治疗前后的神经肽Y、颅内压变化情况.结果 治疗前,两组患者的神经肽Y、颅内压情况比较差异无统计学意义(P＞0.05).治疗后,两组患者的治疗总有效率观察组(94.29％)高于对照组(77.14％);两组患者的不良反应发生率观察组(2.86％)低于对照组(17.14％);两组患者的神经肽Y、颅内压改善情况比较,观察组优于对照组,差异有统计学意义(P＜0.05).结论 脑出血使用呲拉西坦氯化钠治疗,能够有效提升治疗有效率,减少不良反应发生,改善神经肽Y和颅内压情况,可取得较佳的治疗效果,值得推广应用.     

关于举办“妈咪爱与易坦静临床应用有奖病例征集”的通知

<正>妈咪爱(枯草杆菌二联活菌颗粒)上市至今已有20年,用于治疗儿童腹泻、便秘、消化不良、新生儿黄疸等疾病;易坦静(氨溴特罗口服溶液)作为儿童祛痰止咳药于2004年6月上市,现二者均已成为各应用领域的知名品牌。为进一步总结妈咪爱及易坦静的临床应用经验,评估其临床疗效、应用范围及安全性,加强学术交流合作,促进合理用药,北京韩美药品有限公司现联合《中国实用儿科杂志》编委会举办"妈咪爱与易坦静临床应用有奖病例征集活动"。现将有关事项通知如下,欢迎广大儿科医生积极参与。     

阿昔洛韦致头痛3例

1病历摘要2例患者,男,20,21岁,皮肤损伤均在躯干左、右旁侧.1例患者,女,20岁,皮肤损伤为右下肢内侧.既往史健康,化验肝功、胸部X透视、心电图正常.诊断带状疱疹.3例患者在静滴阿昔洛韦液0.9%氯化钠300ml 阿昔洛韦0.5g,滴注过程均无不良反应,滴注后12h,1例女患者出现头痛剧烈,伴有恶心、呕吐、胃肠不适感.另2例男患者分别在滴注后24h,前后出现为前额、两侧颞部持续头痛,不能入睡.     

Glucantime治疗皮肤利什曼病52例疗效观察

本人自2000年8月～2001年2月在突尼斯克比里省医院工作期间采用Glucantime(这是一种五份合成锑剂,其溶液含锑85mg/ml)治疗52例皮肤利什曼病患者,取得满意疗效,现报道如下。     

生理性溶液对角膜上皮细胞微绒毛的影响

扫描电镜下观察了生理盐水、Hanks液及平衡盐溶液(BSS)以滴速30滴/分滴浴0.5～3小时的兔眼角膜上皮细胞微绒毛的变化。生理盐水滴浴0.5小时,角膜上皮微绒毛减少并皱缩成圆钮状;Hanks液及BSS滴浴1.5～3小时,大部分角膜上皮细胞的微绒毛保持正常的细长指状,偶见上皮细胞的微绒毛皱缩变短或呈簇状。讨论了生理性溶液对角膜上皮细胞微绒毛影响的意义。     

不同液体术前急性高容量血液稀释对深静脉血栓病人血液流变学的影响

Objective To investigate the effects of acute hypervolemic hemodilution (AHH) with different fluids on blood rheology in patients with deep vein (femoral and iliac) thrombosis. Methods Thirty ASA I or II patients aged 40-64 yr who had developed deep vein thrombosis in 48 h and were scheduled for embolectomy were randomly divided into 3 groups ( n = 10 each) ; group I normal saline (NS) ; group II 6 % HES 200/0.5 ( HES) ; group IE gelofusine (GEL). AHH was performed with normal saline, 6% HES or gelofusine infusion at 20 ml·kg-1 ·h-1 for 40 min. MAP, HR and SpO2 were monitored. Blood loss, volume of blood transfusion and fluid infused and urine output during operation were recorded. Anesthesia was induced with fentanyl 3-5 fig/kg, etomidate 0.15-0.30 mg/kg, propofol 1-2 mg/kg and succinylcholine 1-2 mg/kg and maintained with 2% isoflurane and propofol infusion at 5-8 mg·kg-1·h-1 and intermittent iv boluses of vecuronium. The patients were mechanically ventilated (VT 8 ml/kg, RR 12 bpm). PaO2 and PaCO2 were maintained within normal range. Venous blood samples were obtained before and after AHH for measurement of hematocrit (Hct), whole blood viscocity (WBV) at low or high shear rates, plasma viscosity, RBC aggregation and RBC deformation. RBC aggregation index and RBC deformation index were calculated. Results MAP and HR were stable in all patients. The amount of blood transfusion and fluid infused was significantly less in group HES and GEL than in group NS. The WBV at low or high shear rates in group HES and GEL, Hct in all 3 groups and RBC aggregation index in group HES were significantly decreased after AHH, but the RBC deformation index was significantly increased in group HES. Conclusion Colloid is better than crystalloid and HES is better than gelofusine in improving intraoperative hypercoagulability and sluggish blood flow.